NCT05686278

Brief Summary

This PMCF study is designed to collect safety and efficacy data on hip hemiarthroplasty surgeries with Corin BiPolar-i shell and the Oceane+ or Meije Duo femoral stem up to 10 years.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
368

participants targeted

Target at P75+ for all trials

Timeline
113mo left

Started Jun 2023

Longer than P75 for all trials

Geographic Reach
1 country

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress23%
Jun 2023Sep 2035

First Submitted

Initial submission to the registry

January 6, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 17, 2023

Completed
5 months until next milestone

Study Start

First participant enrolled

June 29, 2023

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2028

Expected
7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2035

Last Updated

March 18, 2026

Status Verified

March 1, 2026

Enrollment Period

5.2 years

First QC Date

January 6, 2023

Last Update Submit

March 17, 2026

Conditions

Keywords

HemiarthroplastyAcetabulumHip Fractures

Outcome Measures

Primary Outcomes (1)

  • Evaluation of safety of the study devices at 2 years after a hip hemiarthroplasty surgery.

    Intraoperative and postoperative adverse events (hip, device or procedure related) will be recorded.

    2 years

Secondary Outcomes (6)

  • Evaluation of mid-term and long-term safety of the study devices up to 10 years.

    10 years

  • Evaluation of study devices performance and benefit through patient's mobility from baseline to 10-year FU.

    10 years

  • Evaluation of study devices performance and benefit through patient's quality of life from baseline to 10-year FU.

    10 years

  • Radiographic analysis to detect acetabular erosion

    2 years

  • Radiographic analysis to detect femoral stem stability

    2 years

  • +1 more secondary outcomes

Study Arms (1)

Hip hemiarthroplasty with BiPolar i and cemented stems (Meije or Oceane+)

Subjects clinically suitable for a hip hemiarthroplasty surgery with Corin hip devices

Device: Bipolar i and cemented stem (Océane+ or Meije)

Interventions

Hip hemiarthroplasty is a surgical procedure that involves replacing half of the hip joint

Hip hemiarthroplasty with BiPolar i and cemented stems (Meije or Oceane+)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects clinically suitable for a hip hemiarthroplasty surgery with Corin hip devices based on physical examination, medical history and diagnosis such as: non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis in which the acetabulum does not require replacement, treatment of non-union, femoral neck and trochanteric fractures of the proximal femur, revision of failed partial hip replacements in which the acetabulum does not require replacement.

You may qualify if:

  • Both genders.
  • Adult subjects.
  • Subjects clinically suitable for a hip hemiarthroplasty surgery with Corin hip devices based on physical examination, medical history and diagnosis such as: non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis in which the acetabulum does not require replacement, treatment of non-union, femoral neck and trochanteric fractures of the proximal femur, revision of failed partial hip replacements in which the acetabulum does not require replacement.
  • The subject is willing to comply with the required follow-up visits as per protocol.
  • The subject, or a designated trusted person in case the subject is unable to do, has signed a Patient Informed Consent Form (PICF), specific to this study, and approved by the local EC.

You may not qualify if:

  • Subjects with active infection or sepsis or osteomyelitis.
  • Subjects with unsuitable or insufficient bone support preventing proper fixation of the prosthesis.
  • Subject with marked bone loss or bone absorption.
  • Subject with metabolic disorders which may impair bone formation or bone quality.
  • Subjects under guardianship.
  • Subjects under jusicial protection
  • Subjects in the opinion of the Investigator/ investigative team who will be unable to comply with study procedures (Examples: recent psychotic or mania disorders, alcohol, drug or substance abusers) and/or those unable for any medical or other reason to comply with study procedures/visits.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Ch Amboise

Amboise, France, 37403, France

RECRUITING

Polyclinique Henin Beaumont

Hénin-Beaumont, 62110, France

TERMINATED

Hopital Saint Joseph

Paris, 75014, France

RECRUITING

Hopital Diaconesses Croix Saint Simon

Paris, 75020, France

NOT YET RECRUITING

MeSH Terms

Conditions

Hip FracturesOsteoarthritis, HipFemoral Neck Fractures

Condition Hierarchy (Ancestors)

Femoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg InjuriesOsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Christophe HULET, MD, PhD

    University Hospital, Caen

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 6, 2023

First Posted

January 17, 2023

Study Start

June 29, 2023

Primary Completion (Estimated)

September 1, 2028

Study Completion (Estimated)

September 1, 2035

Last Updated

March 18, 2026

Record last verified: 2026-03

Locations